Semi-automated Production of Cell-free Biosensors
Dylan M. Brown,Daniel A. Phillips,David C. Garcia,Anibal Arce,Tyler Lucci,John P. Davies Jr.,Jacob Mangini,Katherine A. Rhea,Casey B. Bernhards,John R. Biondo,Steven M. Blum,Stephanie D. Cole,Jennifer A. Lee,Marilyn S. Lee,Nathan D. McDonald,Brenda Wang,Dale L. Perdue,Walter Thavarajah,Ashty S. Karim,Matthew W. Lux,Michael C. Jewett,Aleksandr E. Miklos,Julius B Lucks
DOI: https://doi.org/10.1101/2024.10.13.618078
2024-10-13
Abstract:Cell-free synthetic biology biosensors have potential as effective in vitro diagnostic technologies for the detection of chemical compounds such as toxins and human health biomarkers. They have several advantages over conventional laboratory-based diagnostic approaches, including being able to be assembled, freeze-dried, distributed, and then used at the point-of-need. This makes them an attractive platform for cheap and rapid chemical detection across the globe. Though promising, a major challenge is scaling up biosensor manufacturing to meet the needs of their multiple uses. Currently, cell-free biosensor assembly during lab-scale development is mostly performed manually by the operator, leading to quality control and performance variability issues. Here we explore the use of liquid handling robotics to manufacture cell-free biosensor reactions. We compare both manual and semi-automated reaction assembly approaches using the Opentrons OT-2 liquid handling platform on two different cell-free gene expression assay systems that constitutively produce colorimetric (LacZ) or fluorescent (GFP) signals. We test the designed protocol by constructing an entire 384-well plate of fluoride sensing cell-free biosensors and demonstrate that they perform closely to expected detection outcomes.
Synthetic Biology